These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 25407397)

  • 1. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
    Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
    Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
    Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
    Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
    Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
    Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
    Xu Z; Sandler DP; Taylor JA
    J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
    Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case-control Study.
    Chamberlain JA; Dugué PA; Bassett JK; Milne RL; Joo JE; Wong EM; Brinkman MT; Stuart GW; Boussioutas A; Southey MC; Giles GG; Mitchell H; English DR; Hodge AM
    Cancer Prev Res (Phila); 2021 Feb; 14(2):233-240. PubMed ID: 32958588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
    Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
    Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis.
    van Veldhoven K; Polidoro S; Baglietto L; Severi G; Sacerdote C; Panico S; Mattiello A; Palli D; Masala G; Krogh V; Agnoli C; Tumino R; Frasca G; Flower K; Curry E; Orr N; Tomczyk K; Jones ME; Ashworth A; Swerdlow A; Chadeau-Hyam M; Lund E; Garcia-Closas M; Sandanger TM; Flanagan JM; Vineis P
    Clin Epigenetics; 2015; 7(1):67. PubMed ID: 26244061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
    O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
    Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
    Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
    FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood.
    Huang YT; Chu S; Loucks EB; Lin CL; Eaton CB; Buka SL; Kelsey KT
    Epigenetics; 2016 Mar; 11(3):227-36. PubMed ID: 26891033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
    Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
    Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking.
    Shenker NS; Polidoro S; van Veldhoven K; Sacerdote C; Ricceri F; Birrell MA; Belvisi MG; Brown R; Vineis P; Flanagan JM
    Hum Mol Genet; 2013 Mar; 22(5):843-51. PubMed ID: 23175441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.